Nature Communications (Nov 2021)

Mesenchymal stromal cell apoptosis is required for their therapeutic function

  • Swee Heng Milon Pang,
  • Joshua D’Rozario,
  • Senora Mendonca,
  • Tejasvini Bhuvan,
  • Natalie L. Payne,
  • Di Zheng,
  • Assifa Hisana,
  • Georgia Wallis,
  • Adele Barugahare,
  • David Powell,
  • Jai Rautela,
  • Nicholas D. Huntington,
  • Grant Dewson,
  • David C. S. Huang,
  • Daniel H. D. Gray,
  • Tracy S. P. Heng

DOI
https://doi.org/10.1038/s41467-021-26834-3
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 19

Abstract

Read online

Mesenchymal stromal cells (MSCs) demonstrate therapeutic benefits in multiple diseases, but the mechanisms remain unclear as infused MSCs do not persist in the body. Here, the authors show that MSC apoptosis is an important mechanistic element, as MSCs rendered genetically incapable of apoptosis lose their ability to ameliorate disease.